How Neuronetics, Inc. stacks up

STIM · against 454 other Healthcare companies listed in US-listed

Growth

96/ 100

Near the top of its peers.

Ranked #21 of 455 · scores higher than 93% of peers

Bars: peers in each 10-point band of the growth score

85 peers with a growth score of 90–100, including STIM · Click a bar to see the companies

Why growth scores 96?

Weighted metrics compared with all Healthcare companies.

Mainly thanks to its revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.

Earnings per share growth is not reported, so it is left out of the score.
faster revenue growth over three years: stronger than 88% of peers. 3-year revenue growth: 31.8% vs peer median 5.8%
faster revenue growth over the last year: stronger than 95% of peers. Revenue growth: 99.2% vs peer median 6.1%

Metric by metric

Position: dot = STIM, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.

Metric	STIM	Peer median	Better than	Position among peers	Weight
Revenue growthHigher is better · 475 reported	99.2%	11.0%	90%		33%
Earnings per share growthHigher is better · 171 reported	Not reported	21.2%	—	—	33%
3-year revenue growthHigher is better · 433 reported	31.8%	11.0%	79%		33%

A metric that is not reported is left out of the score; the other weights are rescaled.

Ranking by growth score

Top 5 and the companies ranked around STIM

Rank	Company	Market cap	Growth	Overall
1	Phathom Pharmaceuticals, Inc.PHAT · US-listed	464M USD	100	53
2	AnaptysBio, Inc.ANAB · US-listed	1.4B USD	99	73
2	CorMedix Inc.CRMD · US-listed	433M USD	99	81
2	ImmunityBio, Inc.IBRX · US-listed	8.8B USD	99	31
2	Insight Molecular Diagnostics Inc.IMDX · US-listed	90M USD	99	27
⋯
21	Geron CorporationGERN · US-listed	598M USD	96	49
21	Century Therapeutics, Inc.IPSC · US-listed	275M USD	96	46
21	Mesoblast LimitedMESO · US-listed	1.9B USD	96	44
21	Orchestra BioMed Holdings, Inc.OBIO · US-listed	334M USD	96	49
21	Neuronetics, Inc.STIM · US-listed	172M USD	96	34
21	Tarsus Pharmaceuticals, Inc.TARS · US-listed	3.4B USD	96	48
35	Agios Pharmaceuticals, Inc.AGIO · US-listed	1.9B USD	95	49
35	BioAge Labs, Inc.BIOA · US-listed	274M USD	95	57
35	Crinetics Pharmaceuticals IncCRNX · US-listed	9.0B USD	95	51

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…